OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?
Matthias Schaefer
Genes (2021) Vol. 12, Iss. 3, pp. 345-345
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

MODOMICS: a database of RNA modification pathways. 2021 update
Pietro Boccaletto, Filip Stefaniak, Angana Ray, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D231-D235
Open Access | Times Cited: 625

The epitranscriptome toolbox
Sharon Moshitch-Moshkovitz, Dan Dominissini, Gideon Rechavi
Cell (2022) Vol. 185, Iss. 5, pp. 764-776
Open Access | Times Cited: 65

MePMe-seq: antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing
Katja Hartstock, Nadine A. Kueck, Petr Špaček, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23

N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
Qihui Wu, Xiaodan Fu, Guoqian Liu, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1

The emerging roles of ac4C acetylation “writer” NAT10 in tumorigenesis: A comprehensive review
Leisheng Wang, Tao Yue, Jingbo Zhai, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127789-127789
Closed Access | Times Cited: 14

Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access

Unveiling the Impact of ApoF Deficiency on Liver and Lipid Metabolism: Insights from Transcriptome-Wide m6A Methylome Analysis in Mice
Xue‐Bin Shen, Mengting Chen, Jian Zhang, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 347-347
Open Access | Times Cited: 3

Targeted Degradation of METTL3 Against Acute Myeloid Leukemia and Gastric Cancer.
Kyubin Hwang, Ju‐Hyeon Bae, Yoo-Lim Jhe, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116843-116843
Closed Access | Times Cited: 3

From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution
Zachary W. Kockler, Dmitry A. Gordenin
Cells (2021) Vol. 10, Iss. 6, pp. 1557-1557
Open Access | Times Cited: 23

Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis
Yuancheng Huang, Chaoyuan Huang, Xiaotao Jiang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 13

The Methylation Game: Epigenetic and Epitranscriptomic Dynamics of 5-Methylcytosine
Adele Alagia, Monika Gullerová
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13

Tet-dependent 5-hydroxymethyl-Cytosine modification of mRNA regulates axon guidance genes in Drosophila
Badri Nath Singh, Hiep Tran, Joseph Kramer, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0293894-e0293894
Open Access | Times Cited: 2

RNA Modifications Meet Tumors
Zhiyuan Yang, Siyu Zhang, Tian Xia, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3223-3243
Open Access | Times Cited: 11

Driving Chromatin Organisation through N6-methyladenosine Modification of RNA: What Do We Know and What Lies Ahead?
Tommaso Selmi, Chiara Lanzuolo
Genes (2022) Vol. 13, Iss. 2, pp. 340-340
Open Access | Times Cited: 10

Epitranscriptomic challenges and promises in metabolic diseases
Despina Sanoudou, Kalliopi Gkouskou, Aristides G. Eliopoulos, et al.
Metabolism (2022) Vol. 132, pp. 155219-155219
Closed Access | Times Cited: 10

ELMo4m6A: A Contextual Language Embedding-Based Predictor for Detecting RNA N6-Methyladenosine Sites
Yongxian Fan, Guicong Sun, Xiaoyong Pan
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2022) Vol. 20, Iss. 2, pp. 944-954
Closed Access | Times Cited: 8

Epitranscriptomics of Ischemic Heart Disease—The IHD-EPITRAN Study Design and Objectives
Vilbert Sikorski, Pasi Karjalainen, Daria Blokhina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6630-6630
Open Access | Times Cited: 11

MePMe-seq: Antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing
Katja Hartstock, Anna Ovcharenko, Nadine A. Kueck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7

RNA methyltransferases in plants: Breakthroughs in function and evolution
Ricardo Ferraz, Sı́lvia Coimbra, Sandra Correia, et al.
Plant Physiology and Biochemistry (2022) Vol. 194, pp. 449-460
Open Access | Times Cited: 6

Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review
Zujian Jin, Jingjing Sheng, Yingying Hu, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3

Potential usages of A-to-I RNA editing patterns as diagnostic biomarkers
David Rodríguez Morales, Mirolyuba Ilieva, Sarah Rennie, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 4, pp. C837-C842
Closed Access | Times Cited: 2

Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis
Jiafeng Wang, Wei Cai, Fen-Sheng Qiu, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 10, pp. 1009-1017
Closed Access | Times Cited: 4

On demand CRISPR-mediated RNA N6-methyladenosine editing
Ying Xu, Fu‐Sen Liang
Genes & Diseases (2022) Vol. 9, Iss. 6, pp. 1389-1390
Open Access | Times Cited: 3

The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling
Kun Zhao, Yukang Mao, Yansong Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top